Cargando…
An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents
Coumarin is an important six-membered aromatic heterocyclic pharmacophore, widely distributed in natural products and synthetic molecules. The versatile and unique features of coumarin nucleus, in combination with privileged sulfonamide moiety, have enhanced the broad spectrum of biological activiti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911621/ https://www.ncbi.nlm.nih.gov/pubmed/35268704 http://dx.doi.org/10.3390/molecules27051604 |
_version_ | 1784666863867789312 |
---|---|
author | Rubab, Laila Afroz, Sumbal Ahmad, Sajjad Hussain, Saddam Nawaz, Iram Irfan, Ali Batool, Fozia Kotwica-Mojzych, Katarzyna Mojzych, Mariusz |
author_facet | Rubab, Laila Afroz, Sumbal Ahmad, Sajjad Hussain, Saddam Nawaz, Iram Irfan, Ali Batool, Fozia Kotwica-Mojzych, Katarzyna Mojzych, Mariusz |
author_sort | Rubab, Laila |
collection | PubMed |
description | Coumarin is an important six-membered aromatic heterocyclic pharmacophore, widely distributed in natural products and synthetic molecules. The versatile and unique features of coumarin nucleus, in combination with privileged sulfonamide moiety, have enhanced the broad spectrum of biological activities. The research and development of coumarin, sulfonamide-based pharmacology, and medicinal chemistry have become active topics, and attracted the attention of medicinal chemists, pharmacists, and synthetic chemists. Coumarin sulfonamide compounds and analogs as clinical drugs have been used to cure various diseases with high therapeutic potency, which have shown their enormous development value. The diversified and wide array of biological activities such as anticancer, antibacterial, anti-fungal, antioxidant and anti-viral, etc. were displayed by diversified coumarin sulfonamides. The present systematic and comprehensive review in the current developments of synthesis and the medicinal chemistry of coumarin sulfonamide-based scaffolds give a whole range of therapeutics, especially in the field of oncology and carbonic anhydrase inhibitors. In the present review, various synthetic approaches, strategies, and methodologies involving effect of catalysts, the change of substrates, and the employment of various synthetic reaction conditions to obtain high yields is cited. |
format | Online Article Text |
id | pubmed-8911621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89116212022-03-11 An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents Rubab, Laila Afroz, Sumbal Ahmad, Sajjad Hussain, Saddam Nawaz, Iram Irfan, Ali Batool, Fozia Kotwica-Mojzych, Katarzyna Mojzych, Mariusz Molecules Review Coumarin is an important six-membered aromatic heterocyclic pharmacophore, widely distributed in natural products and synthetic molecules. The versatile and unique features of coumarin nucleus, in combination with privileged sulfonamide moiety, have enhanced the broad spectrum of biological activities. The research and development of coumarin, sulfonamide-based pharmacology, and medicinal chemistry have become active topics, and attracted the attention of medicinal chemists, pharmacists, and synthetic chemists. Coumarin sulfonamide compounds and analogs as clinical drugs have been used to cure various diseases with high therapeutic potency, which have shown their enormous development value. The diversified and wide array of biological activities such as anticancer, antibacterial, anti-fungal, antioxidant and anti-viral, etc. were displayed by diversified coumarin sulfonamides. The present systematic and comprehensive review in the current developments of synthesis and the medicinal chemistry of coumarin sulfonamide-based scaffolds give a whole range of therapeutics, especially in the field of oncology and carbonic anhydrase inhibitors. In the present review, various synthetic approaches, strategies, and methodologies involving effect of catalysts, the change of substrates, and the employment of various synthetic reaction conditions to obtain high yields is cited. MDPI 2022-02-28 /pmc/articles/PMC8911621/ /pubmed/35268704 http://dx.doi.org/10.3390/molecules27051604 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rubab, Laila Afroz, Sumbal Ahmad, Sajjad Hussain, Saddam Nawaz, Iram Irfan, Ali Batool, Fozia Kotwica-Mojzych, Katarzyna Mojzych, Mariusz An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents |
title | An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents |
title_full | An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents |
title_fullStr | An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents |
title_full_unstemmed | An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents |
title_short | An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents |
title_sort | update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911621/ https://www.ncbi.nlm.nih.gov/pubmed/35268704 http://dx.doi.org/10.3390/molecules27051604 |
work_keys_str_mv | AT rubablaila anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT afrozsumbal anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT ahmadsajjad anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT hussainsaddam anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT nawaziram anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT irfanali anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT batoolfozia anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT kotwicamojzychkatarzyna anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT mojzychmariusz anupdateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT rubablaila updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT afrozsumbal updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT ahmadsajjad updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT hussainsaddam updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT nawaziram updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT irfanali updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT batoolfozia updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT kotwicamojzychkatarzyna updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents AT mojzychmariusz updateonsynthesisofcoumarinsulfonamidesasenzymeinhibitorsandanticanceragents |